SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950137-05-015039
Filing Date
2005-12-16
Accepted
2005-12-16 17:13:06
Documents
7
Period of Report
2005-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a15498e8vk.htm 8-K 34043
2 EXHIBIT 3.1 a15498exv3w1.htm EX-3.1 5455
3 EXHIBIT 4.1 a15498exv4w1.htm EX-4.1 34132
4 EXHIBIT 10.1 a15498exv10w1.htm EX-10.1 91655
5 EXHBIT 99.1 a15498exv99w1.htm EX-99.1 5524
6 EXHIBIT 99.2 a15498exv99w2.htm EX-99.2 4796
7 EXHIBIT 99.3 a15498exv99w3.htm EX-99.3 2956
  Complete submission text file 0000950137-05-015039.txt   180426
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 051270471
SIC: 2836 Biological Products, (No Diagnostic Substances)